S 1 EVALUATION OF ( 1-SARCOSINE , 8-ISOLEUCINE ) ANGIOTENSIN II AS A in THERAPEUTIC AGENT FOR OLEIC ACID-INDUCED PULMONARY EDEMA
暂无分享，去创建一个
[1] T. Petty,et al. Chronic lung disease. , 1989, Postgraduate medicine.
[2] K. Ashutosh,et al. Arterial oxygenation and pulmonary function with Saralasin in chronic lung disease. , 1983, Chest.
[3] G. Feuerstein,et al. Prostacyclin reversal of lethal endotoxemia in dogs. , 1981, The Journal of clinical investigation.
[4] N. Staub. Pulmonary edema due to increased microvascular permeability. , 1981, Annual review of medicine.
[5] E. G. Erdös,et al. Prolylcarboxypeptidase (angiotensinase C) in human lung and cultured cells. , 1981, The Journal of clinical investigation.
[6] E. G. Erdös,et al. Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. , 1978, The Journal of biological chemistry.
[7] Sautkin Mf. Arterial pressure changes in medical institute students , 1976 .
[8] T. Ogihara,et al. Clinical applications of synthetic angiotensin II analogue. , 1974, Japanese circulation journal.
[9] J. Jones,et al. Absolute pressure measurements with hand-dipped and manufactured esophageal balloons. , 1974, Journal of applied physiology.
[10] J. Vane,et al. Metabolism of the Angiotensins in Isolated Perfused Tissues , 1969, Nature.
[11] H. Bachofen,et al. Lung tissue resistance and pulmonary hysteresis. , 1968, Journal of applied physiology.